BIOXXMED AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6 EUR | 0.00% |
|
+20.97% | +34.53% |
| 2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.34M | - | - | - | - | - | |
| 62.59B | - | |||||
| 41.18B | ||||||
| 40.29B | ||||||
| 27.9B | ||||||
| 26.21B |
- Stock Market
- Equities
- T5O Stock
- Charts bioXXmed AG
- Sector Chart
